Quick Answer
MARIMED INC. reported Diluted EPS of $0.04 per share (loss) for fiscal year 2025.
MARIMED INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.04 | -33.3% |
| 2024 | -$0.03 | +25.0% |
| 2023 | -$0.04 | -200.0% |
| 2022 | $0.04 | +100.0% |
| 2021 | $0.02 | +100.0% |
| 2020 | $0.01 | +102.6% |
| 2019 | -$0.39 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.01 | — | — |
| June 30, 2025 | $0.00 | — | +100.0% |
| March 31, 2025 | -$0.01 | — | — |
| September 30, 2024 | $0.00 | +100.0% | — |
| June 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | — | +100.0% |
| September 30, 2023 | -$0.01 | -200.0% | — |
| June 30, 2023 | $0.00 | — | — |
- MARIMED INC. showed a decrease of -33.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, MARIMED INC.’s diluted eps has grown by 89.7% (from $0.39 per share (loss) to $0.04 per share (loss)).
- The most recent figure is from MARIMED INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: